Reversal of immunosuppression in cutaneous T cell lymphoma by anti-CTLA-4 antibody

被引：0
|
作者：
Berger, C. L. [1 ]
Girardi, M. [1 ]
Tigelaar, R. [1 ]
Edelson, R. L. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
698
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [21] Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
    Peggs, Karl S.
    Quezada, Sergio A.
    Chambers, Cynthia A.
    Korman, Alan J.
    Allison, James P.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (08): : 1717 - 1725
  • [22] SORAFENIB ENHANCES THE ANTI-TUMOR EFFECT OF ANTI-CTLA-4 ANTIBODY TO KIDNEY CANCER
    Takanobu, Motoshima
    Yoshihiro, Komohara
    Yoshiaki, Kawano
    Yoshihiro, Wada
    Masatoshi, Eto
    JOURNAL OF UROLOGY, 2013, 189 (04): : E66 - E66
  • [23] Anti-CTLA-4 therapy for malignant mesothelioma
    Guazzelli, Alice
    Bakker, Emyr
    Krstic-Demonacos, Marija
    Lisanti, Michael P.
    Sotgia, Federica
    Mutti, Luciano
    IMMUNOTHERAPY, 2017, 9 (03) : 273 - 280
  • [24] Immunologic impact of anti-CTLA-4 therapy
    Sharma, P.
    Tsavachidou, D.
    Kamat, A.
    Tang, D. Ng
    Chen, H.
    Fu, T.
    Troncoso, P.
    Wolchok, J.
    Logothetis, C. J.
    Allison, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Therapeutic use of anti-CTLA-4 antibodies
    Blank, Christian U.
    Enk, Alexander
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 3 - 10
  • [26] Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody
    Knox, S
    Hoppe, RT
    Maloney, D
    Gibbs, I
    Fowler, S
    Marquez, C
    Cornbleet, PJ
    Levy, R
    BLOOD, 1996, 87 (03) : 893 - 899
  • [27] A novel humanized anti-CTLA-4 antibody compared to ipilimumab in preclinical studies.
    Shi, Qian
    Liu, Yanli
    Yang, Lan
    Ma, Hongli
    Ma, Wencui
    Sun, Ziyong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [28] Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
    Cha, Edward
    Klinger, Mark
    Hou, Yafei
    Cummings, Craig
    Ribas, Antoni
    Faham, Malek
    Fong, Lawrence
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (238)
  • [29] Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
    Ansell, Stephen M.
    Hurvitz, Sara A.
    Koenig, Patricia A.
    LaPlant, Betsy R.
    Kabat, Brian F.
    Fernando, Donna
    Habermann, Thomas M.
    Inwards, David J.
    Verma, Meena
    Yamada, Reiko
    Erlichman, Charles
    Lowy, Israel
    Timmerman, John M.
    CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6446 - 6453
  • [30] Radiation at escalated dose enhances the systemic antitumor efficacy of anti-CTLA-4 antibody
    Takenaka, Wataru
    Takahashi, Yutaka
    Minami, Kazumasa
    Tamari, Keisuke
    Tatekawa, Shotaro
    Katsuki, Shohei
    Yamamoto, Junya
    Matsutani, Hideki
    Koizumi, Masahiko
    Ogawa, Kazuhiko
    CANCER SCIENCE, 2022, 113 : 397 - 397
12345